You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 10, 2024

LIKMEZ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Likmez patents expire, and what generic alternatives are available?

Likmez is a drug marketed by Saptalis Pharms and is included in one NDA. There is one patent protecting this drug.

This drug has five patent family members in five countries.

The generic ingredient in LIKMEZ is metronidazole. There are eighteen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Likmez

A generic version of LIKMEZ was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIKMEZ?
  • What are the global sales for LIKMEZ?
  • What is Average Wholesale Price for LIKMEZ?
Summary for LIKMEZ
International Patents:5
US Patents:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 2
Drug Prices: Drug price information for LIKMEZ
What excipients (inactive ingredients) are in LIKMEZ?LIKMEZ excipients list
DailyMed Link:LIKMEZ at DailyMed
Drug patent expirations by year for LIKMEZ
Drug Prices for LIKMEZ

See drug prices for LIKMEZ

Pharmacology for LIKMEZ

US Patents and Regulatory Information for LIKMEZ

LIKMEZ is protected by one US patents.

Patents protecting LIKMEZ


Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Saptalis Pharms LIKMEZ metronidazole SUSPENSION;ORAL 216755-001 Sep 22, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for LIKMEZ

See the table below for patents covering LIKMEZ around the world.

Country Patent Number Title Estimated Expiration
Brazil 112020014376 composição farmacêutica oral, e, método para tratar uma infecção em um paciente. ⤷  Sign Up
Mexico 2020007494 FORMULACIONES ORALES DE METRONIDAZOL Y METODOS DE TRATAMIENTO DE UNA INFECCION CON LAS MISMAS. (ORAL FORMULATIONS OF METRONIDAZOLE AND METHODS OF TREATING AN INFECTION USING SAME.) ⤷  Sign Up
European Patent Office 3768321 FORMULATIONS ORALES DE MÉTRONIDAZOLE ET MÉTHODES DE TRAITEMENT D'UNE INFECTION FAISANT APPEL À CELLES-CI (ORAL FORMULATIONS OF METRONIDAZOLE AND METHODS OF TREATING AN INFECTION USING SAME) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2019140516 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for LIKMEZ

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0328535 96C0021 Belgium ⤷  Sign Up PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.